– Tidetron brilla en Future Food Asia 2023, obteniendo el premio a la empresa emergente de biotecnología agroalimentaria de más rápido crecimiento en China SINGAPUR, 30 de mayo, 2023 /PRNewswire/ — La séptima edición de la conferencia Future Food Asia (FFA) concluyó en mayo y culminó con un rotundo triunfo para Tidetron Bioworks Technology Co., Ltd. … Read more
TAMPA, Florida, 30 de mayo de 2023 /PRNewswire/ — La FDA de los Estados Unidos otorgó el 24 de mayo de 2023 una aprobación de exención de dispositivo en investigación (EDI) para el balón recubierto de sirolimus (SCB) MagicTouch PTA de Concept Medical Inc para el tratamiento de la enfermedad de la arteria femoral superficial (SFA). … Read more
TAMPA, Flórida, 30 de maio de 2023 /PRNewswire/ — A FDA dos EUA, em 24 de maio de 2023, concedeu uma aprovação de Isenção de Dispositivo Investigacional (IDE) para o Balão Revestido de Sirolimus (SCB) MagicTouch PTA da Concept Medical Inc para o tratamento de Artérias Femorais Superficiais (SFA). Isso marca a quarta aprovação da IDE … Read more
LUND, Sweden, May 30, 2023 /PRNewswire/ — Hansa Biopharma (“Hansa”), a pioneer in enzyme technology for rare immunological conditions, today announced the first patient has been dosed with imlifidase in the GOOD-IDES-02 trial, a global pivotal phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease. Søren Tulstrup, President and CEO, Hansa Biopharma said, “This is … Read more
VADUZ, Liechtenstein, May 30, 2023 /PRNewswire/ — Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, announces today that Medtop recognized RefluxStop™ as the most innovative medical device among all competitors. “We thank Medtop for acknowledging Implantica’s premier commercial product, RefluxStop™, as the most innovative medical device for 2023. … Read more
LUND, Sweden, May 30, 2023 /PRNewswire/ — Hansa Biopharma (“Hansa”), a pioneer in enzyme technology for rare immunological conditions, today announced the first patient has been dosed with imlifidase in the GOOD-IDES-02 trial, a global pivotal phase 3 trial in anti-glomerular basement membrane (anti-GBM) disease. Søren Tulstrup, President and CEO, Hansa Biopharma said, “This is … Read more
TAMPA, Florida, 30. Mai 2023 /PRNewswire/ — Die US-amerikanische Zulassungsbehörde FDA hat am 24. Mai 2023 eine IDE-Zulassung (Investigational Device Exemption) für den Sirolimus-beschichteten Ballon (SCB) MagicTouch PTA von Concept Medical Inc. zur Behandlung von oberflächlichen Oberschenkelarterien (Superficial Femoral Arteries, SFA) erteilt. Dies ist die vierte IDE-Zulassung für den Sirolimus-beschichteten Ballon des Unternehmens. Concept Medical’s fourth … Read more
It was confirmed the presence of Prophage and Jamphage in the Alkalihalobacillus clausii Prophage and Jamphage are expected to play a substantial role in bacterial survival and immune regulation in the body. BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced today the identification of Prophage and (non-) … Read more
DUBLIN, May 29, 2023 /PRNewswire/ — The “CBD Pet Products Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering. The global CBD pet products market is expected to grow at a CAGR of around 28.9% during 2023-2030. Companies Mentioned Canna-Pet CBD Living Charlotte’s Web Fomo Bones GCH Inc. … Read more
NEW YORK, May 29, 2023 /PRNewswire/ — The clinical alarm management market is set to grow by USD 2,393.76 million from 2022 to 2027. The market is estimated to be progressing at a CAGR of 15.56% during the forecast period. Discover Health Care Technology industry potential and make informed business decisions based on qualitative and quantitative evidence highlighted in … Read more